Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.34 is 102% above its 4-year average of 0.17, near the high end of its 4-year range (0.00–0.43).
As of the fiscal period ended Tuesday, June 30, 2026. 88.09% above its 12-month average of 0.18.
Reported quarterly quick ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 0.34.
QUICK RATIO (ACID-TEST)
0.34
QUICK RATIO (ACID-TEST) AVG TTM
0.18
QUICK RATIO (ACID-TEST) AVG 3Y
0.22
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+88.09%
CURRENT VS 3Y AVG
+54.59%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 502 covered companies
CURRENT VS SECTOR MEDIAN
-88.58%
vs the sector median at left
Citius Oncology, Inc.
Market Cap
$81.22M
Quick Ratio (Acid-Test)
0.34
TTM Avg
0.18
3Y Avg
0.22
5Y Avg
N/A
Market Cap
$79.46M
Quick Ratio (Acid-Test)
1.00
TTM Avg
2.08
3Y Avg
2.75
5Y Avg
4.86
Market Cap
$83.49M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.96M
Quick Ratio (Acid-Test)
7.03
TTM Avg
3.05
3Y Avg
3.90
5Y Avg
4.20
Market Cap
$84.00M
Quick Ratio (Acid-Test)
5.74
TTM Avg
2.67
3Y Avg
4.44
5Y Avg
7.03
Market Cap
$84.70M
Quick Ratio (Acid-Test)
1.98
TTM Avg
0.61
3Y Avg
1.40
5Y Avg
2.59
Market Cap
$84.75M
Quick Ratio (Acid-Test)
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
Market Cap
$86.69M
Quick Ratio (Acid-Test)
1.01
TTM Avg
1.14
3Y Avg
1.20
5Y Avg
1.25
Market Cap
$87.86M
Quick Ratio (Acid-Test)
3.30
TTM Avg
5.38
3Y Avg
8.10
5Y Avg
12.75
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Citius Oncology, Inc. (CTOR) | $81.22M | 0.34 | 0.18 | 0.22 | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | 1.00 | 2.08 | 2.75 | 4.86 |
| Conexeu Sciences Inc. (CNXU)vs › | $83.49M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.96M | 7.03 | 3.05 | 3.90 | 4.20 |
| Humacyte, Inc. (HUMA)vs › | $84.00M | 5.74 | 2.67 | 4.44 | 7.03 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | 1.98 | 0.61 | 1.40 | 2.59 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | 7.99 | 9.12 | 12.06 | 14.25 |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 1.01 | 1.14 | 1.20 | 1.25 |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | 3.30 | 5.38 | 8.10 | 12.75 |
| Hyperfine, Inc. (HYPR)vs › | $74.35M | 5.45 | 4.61 | 8.17 | 10.19 |
Quick Ratio
0.34
Excludes inventory
Current Ratio
0.73
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.34 |
| 2026-03-31 | 0.12 |
| 2025-12-31 | 0.32 |
| 2025-09-30 | 0.11 |
| 2025-06-30 | 0.02 |
| 2025-03-31 | 0.05 |
| 2024-12-31 | 0.06 |
| 2024-09-30 | 0.08 |
| 2024-06-30 | 0.32 |
| 2024-03-31 | 0.32 |
| 2023-12-31 | 0.33 |
| 2023-09-30 | 0.37 |
| 2023-06-30 | 0.43 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
